You searched for "medicines"

1153 results found

insitro and UK’s INSIGHT at Moorfields Eye Hospital announce collaboration to expand research efforts in neurodegeneration and related conditions

The world’s largest bioresource of eye images offers window into human health and serves as basis of a new AI foundation model to boost drug discovery. insitro, a machine learning-enabled drug discovery and development company, and the INSIGHT Health Data...

IVT Aflibercept 2mg in nAMD: XTEND at 3 years

This study investigated the long-term, effectiveness and safety of IVT-AFL 2mg for neovascular age-related macular degeneration (nAMD). XTEND was a multicentre, observational, prospective study, which was conducted across 127 centres across 17 countries with a follow-up period of 36 months....

Vabysmo receives NICE approval

The National Institute for Health and Care Excellence (NICE) has recently approved Vabysmo▼(faricimab) for treating adults with visual impairment due to macular oedema secondary to branch and central retinal vein occlusion (BRVO and CRVO). The NICE approval of Vabysmo was...

Brexit, for richer, for poorer: prospects for post-withdrawal Britain

The people of the United Kingdom voted by 52% to 48% to leave the European Union (EU) in June 2016, a referendum decision intended by a slim majority to restore national self-determination and achieve what many believed to be a...

Codifying ‘care’ and ‘cure’ behaviours of artificial intelligence systems: now out in Nature Medicine

A new publication in Nature Medicine discusses 'Building a code of conduct for AI-driven clinical consultations' The diversity of AI applications in medicine is growing at an accelerating rate, with that trend set to continue as technology develops. This diversity...

Saving sight and changing lives: working with Syrian refugees in Jordan

Two ophthalmologists from the Emory Eye Center share their three-year experience of treating refugees in the camps in Jordan. Jordan currently hosts an estimated 1.4 million Syrian people who have fled the war in their home country. Cataract & Cornea...

An ophthalmology elective in Kandy, Sri Lanka

On my first day at The Centre for Sight, Kandy General Hospital, I observed an enucleation. The surgeons worked with quiet precision, preserving the extraocular muscles for prosthesis placement. But when the time came, it became clear that the prosthesis...

Pharmacopoeia of the Royal Infirmary of Edinburgh

The compact volume depicted in Figure 1 bears the simple title Pharmacopoeia. The book originally belonged to the author’s father, the late John King. A pharmacist by profession, John King maintained a keen interest in matters pertaining to pharmaceutical history....

Blind Faith: In Conversation with Mariya Moosajee

In light of the BBC releasing Blind Faith: Do genetic eye disease ‘treatments' work? earlier this year, a documentary which follows BBC journalist Ramadan Younes as he investigates practitioners who falsely claim to have ‘treatments’ for genetic eye disease, Eye...

Regulatory approval for the use of AI as a medical device

A study led by researchers at Moorfields Eye Hospital and UCL Institute of Ophthalmology examined 36 ‘artificial intelligence as a medical device’ tools approved by regulators in Australia, Europe and the US, identifying that 19% had no published peer-reviewed data...

OCT Angiography in Retinal and Macular Diseases

OCT angiography (OCT-A) is based on the concept that in a static eye, the only moving structure in the fundus of the eye is blood flowing through the vessels. This book explains how the technique allows a depth-resolved analysis and...

Introduction of the Mydriasert insert at the Manchester Royal Eye Hospital

The authors report on a study to examine the effects of the Mydriasert insert on time, effects, patient comfort and tolerability at Manchester Royal Eye Hospital. Mydriasert is an insoluble ophthalmic insert indicated for mydriasis prior to ophthalmic surgery, which...